The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / GSK Wins U.S. Shingles Vaccine Approval, U.K. Nod for Gene Therapy

GSK Wins U.S. Shingles Vaccine Approval, U.K. Nod for Gene Therapy

October 23, 2017 • By Ben Hirschler

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Older adults are most at risk of shingles, a painful, often debilitating blistering rash that results from reactivation of the varicella zoster virus that causes chickenpox and remains latent in those who have had that disease.

You Might Also Like
  • GlaxoSmithKline’s Shingles Vaccine Gets Approval in Canada
  • The Effect of Tofacitinib on Live Vaccine Responses
  • GSK Shuts U.S. Plant Due to Bacteria

Shingrix contains a component from Agenus, which is entitled to royalties on future sales.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Meanwhile, Britain’s National Institute for Health and Care Excellence (NICE) said on Monday that it had approved GSK’s gene therapy Strimvelis for treating ADA-SCID—better known as “bubble boy” disease—despite its steep price tag of 594,000 euros ($698,000).

Infants with the condition need to be kept in isolation to avoid infections and the cost to the state health service can run to millions of pounds, so a one-off genetic cure can prove cost-effective even at a very high price.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: FDA approval, shingles, Shingrix, U.S. Food and Drug Administration (FDA), vaccine

You Might Also Like:
  • GlaxoSmithKline’s Shingles Vaccine Gets Approval in Canada
  • The Effect of Tofacitinib on Live Vaccine Responses
  • GSK Shuts U.S. Plant Due to Bacteria
  • Shingles Vaccination Not at Goal Levels for U.S. Seniors

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)